Tony Kingsley takes over the reins at Scholar Rock; Idorsia taps pharma vet Patricia Torr for new US ops
→ Scholar Rock — which partnered with Gilead back in 2018 for a discovery pact for fibrotic diseases — has passed the CEO and president baton down to Tony Kingsley, who is taking over from Nagesh Mahanthappa. Kingsley joined the company’s board of directors in May. Prior to his new role, Kingsley was CEO and president of Taris Bio (acquired by Janssen Pharmaceuticals). In addition, he served as president and COO of The Medicines Company and held positions at Biogen and McKinsey & Company among others.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.